IntroductionShort bowel syndrome (SBS) is the clinical state of malabsorption and malnutrition that occurs following small bowel resection (SBR). 1 Surgical resection of the small bowel may be required for the treatment of a range of conditions including congenital bowel abnormalities and necrotising enterocolitis in children and Crohn disease, trauma and malignancy in adults. Although the underlying reason for SBR between adults and children may differ, the clinical manifestations and consequences of SBS are similar. The symptoms of SBS reflect the loss of absorptive surface area and functional disturbance of the Background and objectives: Following small bowel resection (sBR), the luminal environment is altered, which contributes to clinical manifestations of short bowel syndrome (sBs) including malabsorption, mucosal inflammation and bacterial overgrowth. however, the impact of sBR on the colon has not been well-defined. The aims of this study were to characterize the colonic microbiota following sBR and to assess the impact of sBR on mucosal inflammation in the colon.Results: analysis of the colonic microbiota demonstrated that there was a significant level of dysbiosis both two and six weeks post-sBR, particularly in the phylum Firmicutes, coupled with a decrease in overall bacterial diversity in the colon. This decrease in diversity was associated with an increase in colonic inflammation six weeks post-surgery.Methods: Female (4-week old) piglets (5-6/group) received a 75% sBR, a transection (sham) or no surgery. compositional analysis of the colonic microbiota was performed by high-throughput sequencing, two-and six-weeks post-surgery. The gene expression of the pro-inflammatory cytokines interleukin (IL)-1β, IL-6, IL-8, IL-18 and tumor necrosis factor (TNF)-α in the colonic mucosa was assessed by qRT-pcR and the number of macrophages and percentage inducible nitric oxide synthase (iNOs) staining in the colonic epithelium were quantified by immunohistochemistry.Conclusions: sBR significantly decreased the diversity of the colonic microbiota and this was associated with an increase in colonic mucosal inflammation. This study supports the hypothesis that sBR has a significant impact on the colon and that this may play an important role in defining clinical outcome.